Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 6, 1997, Pages 1231-1236

  Hoggard, Patrick G ^a   Kewn, Stephen ^a   Barry, Michael G ^a   Khoo, Saye H ^a   Back, David J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; DAPSONE; ELONGATION FACTOR; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; ITRACONAZOLE; LAMIVUDINE; LOBUCAVIR; RANITIDINE; RIBAVIRIN; RIFAMPICIN; SORIVUDINE; STAVUDINE; SULFAMETHOXAZOLE; THYMIDINE DERIVATIVE; TRIMETHOPRIM; ZALCITABINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MONONUCLEAR CELL; PHOSPHORYLATION; PRIORITY JOURNAL;

EID: 0030957788     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.6.1231     Document Type: Article

References (33)

1. Ahluwalia, G., D. A. Cooney, H. Mitsuya, A. Fridland, K. P. Flora, Z. Hao, M. Dalal, S. Broder, and D. G. Johns. 1987. Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivity. Biochem. Pharmacol. 36:3797-3800.
2. Aronoff, G. R., R. F. Bergstrom, S. T. Pottratz, R. S. Sloan, R. L. Wolen, and L. Lemberger. 1984. Fluoxetine kinetics and protein binding in normal and impaired renal function. Clin. Pharmacol. Ther. 36:138-144.
3. Baba, M., R. Pauwels, J. Balzarini, P. Herdewijn, E. De Clercq, and J. Desmyter. 1987. Ribavirin antagonizes inhibitory effects of pyrimidine 2′,3′-dideoxynucleosides but enhances inhibitory effects of purine 2′,3′-dideoxynucleosides on replication of human immunodeficiency virus in vitro. Antimicrob. Agents Chemother. 31:1613-1617.
4. Baba, M., R. Pauwels, P. Herdewijn, E. De Clercq, J. Desmyter, and M. Vandeputte. 1987. Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro. Biochem. Biophys. Res. Commun. 142:128-134.
5. Balzarini, J., P. Herdewijn, and E. De Clercq. 1989. Differential patterns of intracellular metabolism of 2′,3′-dideoxy-2′,3′-didehydrothymidine and 3′-azido-2′,3′-deoxythymidine, two potent anti-human immunodeficiency virus compounds. J. Biol. Chem. 264:6127-6133.
6. Balzarini, J., G.-J. Kang, M. Dalal, P. Herdewijn, E. De Clercq, S. Broder, and D. G. Johns. 1987. The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2′,3′-didehydro-2′,3′-dideoxyribonucleosides: a comparison with their parental 2′,3′-dideoxyribonucleosides. Mol. Pharmacol. 32:162-167.
7. Barry, M., S. Khoo, D. J. Back, G. J. Veal, P. G. Hoggard, S. Gibbons, E. Wilkins, O. Williams, and A. Brekenridge. 1996. The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites. AIDS 10:1361-1367.
8. Blakley, R. L., F. C. Harwood, and K. D. Huff. 1990. Cytostatic effects of 2′,3′-dideoxyribonucleosides on transformed human hemopoietic cell lines. Mol. Pharmacol. 37:328-332.
9. Browne, M. J., K. H. Mayer, S. B. D. Chafee, M. N. Dudley, M. R. Posner, S. M. Steinberg, K. K. Graham, S. M. Geletko, S. H. Zinner, S. L. Denamn, L. M. Dunkle, S. Kaul, C. McLaren, G. Skowron, N. M. Kouttab, T. A. Kennedy, A. B. Weitberg, and G. A. Curt. 1993. 2′,3′-Didehydro-3′-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial. J. Infect. Dis. 167:21-29.
10. Burger, D. M., P. L. Meenhorst, C. H. W. Koks, and H. Beijnen. 1993. Pharmacokinetic interaction between rifampin and zidovudine. Antimicrob. Agents Chemother. 37:1426-1431.
11. Cammack, N., P. Rouse, C. L. P. Marr, P. J. Reid, R. E. Boehme, J. A. V. Coates, C. R. Penn, and J. M. Cameron. 1992. Cellular metabolism of (-) enantiomeric 2′-deoxy-3′-thiacytidine. Biochem. Pharmacol. 43:2059-2064.
12. Chen, C.-H., and Y.-C. Cheng. 1992. The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound, 2′,3′-dideoxycytidine. J. Biol. Chem. 267:2856-2859.
13. Delta Coordinating Committee. 1996. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet 348: 283-291.
14. Eksborg, S., H. Ehrsson, and I. Andersson. 1979. Reversed phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol. J. Chromatogr. Biomed. Appl. 164:479-486.
15. Hansen, M. B., S. E. Nielsen, and K. Berg. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119:203-210.
16. Ho, H.-T., and M. J. M. Hitchcock. 1989. Cellular pharmacology of 2′,3′-dideoxy-2′,3′-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus. Antimicrob. Agents Chemother. 33:844-849.
17. Hoggard, P. G., G. J. Veal, M. J. Wild, M. G. Barry, and D. J. Back. 1995. Drug interactions with zidovudine phosphorylation in vitro. Antimicrob. Agents Chemother. 39:1376-1378.
18. Klecker, R. W., Jr., J. M. Collins, R. C. Yarchoan, R. Thomas, N. McAtee, S. Broder, and C. E. Myers. 1988. Pharmacokinetics of 2′,3′-dideoxycytidine in patients with AIDS and related disorders. J. Clin. Pharmacol. 28:837-842.
19. Kremers, P., J. Duvivier, and C. Heusghem. 1974. Pharmacokinetic studies of cotrimoxazole in man after single and repeated doses. J. Clin. Pharmacol. 14:112-117.
20. Laskin, O. L., J. A. Longstreth, C. C. Hart, D. Scavuzzo, C. M. Kalman, J. D. Connor, and R. B. Roberts. 1987. Ribavirin disposition in high risk patients for acquired immunodeficiency syndrome. Clin. Pharmacol. Ther. 41:546-555.
21. Mansuri, M. M., J. E. Starrett, I. Ghazzouli, M. J. M. Hitchcock, R. Z. Sterzycki, V. Brankovan, T.-S. Lin, E. M. August, W. H. Prussoff, J.-P. Sommadossi, and J. C. Martin. 1989. 1-(2,3-Dideoxy-β-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent. J. Med. Chem. 32:461-466.
22. Merrill, D. P., M. Moonis, T.-C. Chou, and M. S. Hirsch. 1996. Lamivudine or stavudine in two- and three-drug combinations against human immunodeficiency virus type 1 replication in vitro. J. Infect. Dis. 173:355-364.
23. Murray, H. W., K. E. Squires, W. Weiss, S. Sledz, H. S. Sacks, J. Hassett, A. Cross, R. E. Anderson, and L. M. Dunkle. 1995. Stavudinc in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089. J. Infect. Dis. 171(Suppl. 2):S123-S130.
24. Sommadossi, J.-P. 1993. Nucleoside analogs: similarities and differences. Clin. Infect. Dis. 16(Suppl. 1):S7-S15.
25. Sommadossi, J.-P., and R. Carlisle. 1987. Toxicity of 3′-azido-3′-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human progenitor cells in vitro. Antimicrob. Agents Chemother. 31:452-454.
26. Taburet, A.-M., C. Katlama, C. Blanshard, G. Zorza, D. Gazzard, E. Dohin, B. G. Gazzard, C. Frostegard, and E. Singlas. 1992. Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients. Antimicrob. Agents Chemother. 36:1821-1824.
27. Van Leeuwen, R., C. Katlama, V. Kitchen, C. A. B. Boucher, R. Tubiana, M. McBride, D. Ingrand, J. Weber, A. Hill, H. McDade, and S. A. Danner. 1995. Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: a phase I/II study. J. Infect. Dis. 171:1166-1171.
28. Veal, G. J., M. G. Barry, and D. J. Back. 1995. Zalcitabine (ddC) phosphorylation and drug interactions. Antiviral Chem. Chemother. 6:379-384.
29. Veal, G. J., P. G. Hoggard, M. G. Barry, S. Khoo, and D. J. Back. 1996. Interaction between 3TC (lamivudine) and other nucleoside analogues for intracellular phosphorylation. AIDS 10:546-548.
30. Veal, G. J., M. J. Wild, M. G. Barry, and D. J. Back. 1994. Effects of dideoxyinosine and dideoxycytosine on the intracellular phosphorylation of zidovudine in human mononuclear cells. Br. J. Clin. Pharmacol. 38:323-328.
31. Vogt, M. W., K. L. Hartshorn, P. A. Furman, T.-C. Chou, J. A. Fyfe, L. A. Coleman, C. Crumpacker, R. T. Schooley, and M. S. Hirsch. 1987. Ribavirin antagonizes the effect of azidothymidine on HIV replication. Science 235: 1376-1379.
32. Zhu, Z., H.-T. Ho, M. J. Hitchcock, and J.-P. Sommadossi. 1990. Cellular pharmacology of 2′,3′-didehydro-2′,3′-dideoxythymidine (d4T) in human peripheral blood mononuclear cells. Biochem. Pharmacol. 39:R15-R19.
33. Zhu, Z., M. J. M. Hitchcock, and J.-P. Sommadossi. 1991. Metabolism and DNA interaction of 2′,3′-didehydro-2′,3′-dideoxythymidine in human bone marrow cells. Mol. Pharmacol. 40:838-845.